MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents-Reference-Cited by-同舟云学术

MERTK Mediates Intrinsic and Adaptive Resistance to AXL-targeting Agents

Published:2018-08-09 Issue:11 Volume:17 Page:2297-2308
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

McDaniel Nellie K.,Cummings Christopher T.,Iida Mari,Hülse Justus,Pearson Hannah E.,Vasileiadi Eleana,Parker Rebecca E.,Orbuch Rachel A.,Ondracek Olivia J.,Welke Noah B.,Kang Grace H.,Davies Kurtis D.,Wang Xiaodong,Frye Stephen V.,Earp H. Shelton^ORCID,Harari Paul M.,Kimple Randall J.^ORCID,DeRyckere Deborah,Graham Douglas K.,Wheeler Deric L.

Funder

HHS | National Institutes of Health (NIH)

University of Wisconsin-Madison (UW)

University of Wisconsin Carbone Cancer Center (UWCCC)

JILA, University of Colorado (JILA)

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MERTK Is a Potential Therapeutic Target in Ewing Sarcoma;Cancers;2024-08-12

2. MERTK Inhibition as a Targeted Novel Cancer Therapy;International Journal of Molecular Sciences;2024-07-12

3. Discovery of Dual MER/AXL Kinase Inhibitors as Bifunctional Small Molecules for Inhibiting Tumor Growth and Enhancing Tumor Immune Microenvironment;Journal of Medicinal Chemistry;2024-06-24

4. Disrupting EGFR–HER2 Transactivation by Pertuzumab in HER2-Positive Cancer: Quantitative Analysis Reveals EGFR Signal Input as Potential Predictor of Therapeutic Outcome;International Journal of Molecular Sciences;2024-05-29

5. MerTK Drives Proliferation and Metastatic Potential in Triple-Negative Breast Cancer;International Journal of Molecular Sciences;2024-05-08